Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086541
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2004-07-02
Brief Title:
Daily-Dose Consensus Interferon and Ribavirin Efficacy of Combined Therapy
Sponsor:
Bausch Health Americas Inc
Organization:
Bausch Health Americas Inc
Organization Data
Organization:
Bausch Health Americas Inc
Class:
INDUSTRY
Study ID:
IRHC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bausch Health Americas Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None